a pilot phase ii study of neoadjuvant triplet chemotherapy phase ib pilot study to evaluate reparixin in combination with igs/bipm pilot project: gps carrier phase for time/frequency risk biomarkers by high-dose omega-3 fatty acids: phase ii pilot risk biomarkers by high-dose omega-3 fatty acids: phase ii pilot